Huijts, Charlotte M.
,
Lougheed, Sinéad M.
Bodalal, Zuhir
van Herpen, Carla M.
Hamberg, Paul
Tascilar, Metin
Haanen, John B.
Verheul, Henk M.
de Gruijl, Tanja D.
van der Vliet, Hans J.
Funding for this research was provided by:
KWF Kankerbestrijding (VU 2011-5144)
Novartis (Novartis)
Article History
Received: 6 June 2018
Accepted: 12 December 2018
First Online: 17 January 2019
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
: ClinicalTrials.gov Identifier NCT01462214, Netherlands Trial Register number NTR3085. The study was conducted in accordance with the Declaration of Helsinki and consistent with International Conference on Harmonization (ICH) Guidelines for Good Clinical Practice. The Medical Ethical Committee of the VU University Medical Center, Amsterdam, the Netherlands and the Central Committee on Research Involving Human Subjects (CCMO) approved the study protocol.
: All patients gave written informed consent.